Seven predictions for VC's 2022

Mapping European VC's 2021; Elizabeth Holmes found guilty on four counts; Thoma Bravo heads software buyout boom; Amylyx Pharma sets IPO terms
Read online | Don't want to receive these emails? Manage your subscription.
PitchBook
Log in
The Daily Pitch: VC, PE and M&A
January 4, 2022
Like our newsletter? The data comes from the PitchBook Platform — our data software for VC, PE and M&A
Ads
In today's Daily Pitch, you'll find:
  • The future of SPACs, the continuing rise in corporate VC and more PitchBook predictions for the venture industry in 2022.

  • Thoma Bravo dominated what was a banner year for PE-backed software buyouts.

  • A breakdown of where European VC funding landed in 2021.
Today's Top Stories
After a year for the record books, what will shape US VC in 2022?
(peterschreiber.media/Getty Images)
The US VC industry shattered records left and right in 2021, as the private markets raced through economic recovery and soared to new heights. What's in store for next year?

Our 2022 US Venture Capital Outlook details seven predictions from PitchBook analysts on the trends that will shape VC in 2022, from the future of SPACs to the continued expansion of corporate investment. The forecasts include:
  • US investors will make more foreign investments than ever before.

  • At least 25% of all 2020 SPACs will not execute a deal prior to the two-year mark.

  • More than 1,500 corporate VCs will make a deal in the US this year.
read it now
 
Share:   Email    LinkedIn    Twitter    Facebook
Thoma Bravo dominates PE's record year for software buyouts
(kentoh/Getty Images)
Private equity bet big on software companies in 2021, but Thoma Bravo outshone all other firms by landing five of the top 10 largest global buyouts in the sector and leading the way in take-private deals.

Software investment has been on a red-hot run, especially since the onset of the pandemic. But the sector is not entirely without risks.
read more
 
Share:   Email    LinkedIn    Twitter    Facebook
Hot or not: Where European VC funding went in 2021
(mikkelwilliam/Getty Images)
Venture capital investment in Europe and Israel crossed the €100 billion (around $113 billion) mark for the first time ever in 2021, beating 2020's record by 115%.

Many of the region's biggest economies, including the UK and Germany, doubled their fundraising totals from the previous year. Smaller VC hubs, however, saw some of the biggest boosts as the shift to remote work lessened the importance of location.

Check out our map and details on seven key regions to see where VC money went in 2021.
read more
 
Share:   Email    LinkedIn    Twitter    Facebook
Recommended Reads
The pandemic has redrawn corporate policies and caused many major companies to offer work location flexibility. But who goes into the office and when largely depends on where employees fall on the org chart. [Bloomberg]

Meet the new AI auditing startups on a mission to prove that responsibility can also be profitable. [Protocol]

Instant delivery startups have rushed to expand in large cities, resulting in increased expenses and causing many to test major business model changes. [The Information]
Ads
Since yesterday, the PitchBook Platform added:
607
Deals
1552
People
434
Companies
23
Funds
See what our data software can do
 
Quick Takes
  The Daily Benchmark  
  2019 Vintage Global Growth Funds  
  People  
  Former Theranos CEO Elizabeth Holmes found guilty on four charges  
  VC Deals  
  Aimmo lands $12M for data labeling tech  
  SoftBank backs Brazil's Abstra  
  PE Deals  
  Aisling, Court Square to sell Medical Knowledge Group to Novo in $1.1B+ deal  
  Addman Engineering lands Castheon  
  Exits & IPOs  
  Amylyx Pharma sets IPO terms  
  Vigil Neuro plans public debut  
 
 
Ads
The Daily Benchmark
2019 Vintage Global Growth Funds
Median IRR
18.90%
Top Quartile IRR
51.49%
1.29x
Median TVPI
Select top performers
Providence Strategic Growth IV
Insight Venture Partners XI
Dyal Capital Partners IV
*IRR: net of fees
34 Funds in Benchmark »
Check out the latest version of PitchBook Benchmarks
Ads
People
Former Theranos CEO Elizabeth Holmes found guilty on four charges
Elizabeth Holmes, former CEO of now defunct blood-testing company Theranos, has been found guilty on four of 11 charges in a criminal trial. Theranos received extensive backing from investors including Draper Fisher Jurvetson, Black Diamond Ventures and Sandbox Industries, according to PitchBook data. Sunny Balwani, former president and COO of Theranos, faces a separate fraud trial that's reportedly set to begin in February.
View details
 
 
VC Deals
Aimmo lands $12M for data labeling tech
South Korea-based Aimmo has raised a $12 million Series A from investors including DS Asset Management, Industrial Bank of Korea, Hanwha Investment & Securities and S&S Investment, TechCrunch reported. Founded in 2016, the software company is the creator of a data annotation and AI data labeling platform.
Additional Investors:
Korea Asset Investment Securities, Toss Investment, VentureField
View round
 
View similar company »
 
SoftBank backs Brazil's Abstra
Abstra, the developer of a no-code platform for building apps, has raised a $2.3 million round led by SoftBank's Latin America Fund, TechCrunch reported. Founded in 2020, the Rio de Janeiro-based startup was a member of Y Combinator's spring 2021 cohort.
View round
 
View similar company »
 
PE Deals
Aisling, Court Square to sell Medical Knowledge Group to Novo in $1.1B+ deal
Court Square Capital Partners and Aisling Capital have agreed to sell Medical Knowledge Group, a provider of marketing services to biopharma companies, to life sciences investor Novo Holdings, with Axios reporting the deal has an enterprise valuation of $1.15 billion. Court Square acquired New York-based MKG in 2020 from WindRose Health Investors at a reported enterprise value of about $330 million.
View deal
 
View similar company »
 
Addman Engineering lands Castheon
American Industrial Partners-backed Addman Engineering has acquired Castheon, a California-based provider of additive manufacturing processes and metals printing.
View details
 
View 3 investments »
 
PitchBook Webinar: 2022 Private Equity Outlook
Private equity defied all expectations in 2021, beginning with a quick recovery from its slump in 2020 and ending the year on record-breaking numbers. Following these unprecedented results, many are watching the space, interested to see if these trends will continue.

Join our PitchBook experts on Jan. 6 for a discussion on emerging trends, noteworthy PE activity and predictions for what will follow in 2022.

Sign up now
Share:   Email    LinkedIn    Twitter    Facebook
Exits & IPOs
Amylyx Pharma sets IPO terms
Biotech startup Amylyx Pharmaceuticals is seeking to raise up to $175 million at a fully diluted valuation of more than $1.1 billion in its upcoming IPO. Cambridge, Mass.-based Amylyx is developing therapies for ALS and other neurodegenerative diseases. The company was valued at $580 million last year, according to PitchBook data, and has received backing from investors including Viking Global and Morningside.
View details
 
View 5 competitors »
 
Vigil Neuro plans public debut
Vigil Neuroscience, a developer of antibody therapies for neurodegenerative diseases, plans to sell 7 million shares for between $15 and $17 apiece in its upcoming IPO. A midpoint pricing would raise $112 million and give the company a fully diluted valuation of about $491 million. Based in the Boston area, the company plans to trade on the Nasdaq under the symbol VIGL.
View details
 
View similar company »
 
Chart of the Day
"In Q3 2021, valuations in the UK & Ireland across all quartiles paced strongly above 2020 figures. The late-stage median valuation spiked to €15.8 million, 52.9% higher than the peak in 2020. ... It is clear that the UK & Ireland has remained the main VC hub of Europe despite Brexit. Although some operations have had to move back into the EU, VC dealmaking and valuations have developed impressively."

Source: PitchBook's Q3 2021 European VC Valuations Report
About PitchBook | Terms of use | Advertise with us | Contact

Follow us:   in   twtr   fb

This email was sent to pitchbook@quicklydone.com via the PitchBook Platform.

Do you want to change your email address, get a different edition or unsubscribe? Manage your subscription here.

© 2022 PitchBook Data. All rights reserved.
Venture capital, private equity and M&A financial information technology provider.

No comments: